Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Immune Checkpoint Inhibition In Solid Tumor Patients With Homologous Recombination Repair Deficiency

NCT03274661 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT03274661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03274661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Immune Checkpoint Inhibition In Solid Tumor Patients With Homologous Recombination Repair Deficiency
Lead sponsor
Baptist Health South Florida
Phase
Phase 2
Overall status
Completed
Start date
November 3, 2017
Completion date
March 19, 2022
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, adult